ethylisopropylamiloride has been researched along with Acute Promyelocytic Leukemia in 2 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez-Sala, D | 1 |
| Collado-Escobar, D | 1 |
| Mollinedo, F | 1 |
| Ladoux, A | 1 |
| Krawice, I | 1 |
| Damais, C | 1 |
| Frelin, C | 1 |
2 other studies available for ethylisopropylamiloride and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Intracellular alkalinization suppresses lovastatin-induced apoptosis in HL-60 cells through the inactivation of a pH-dependent endonuclease.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amiloride; Apoptosis; Cell Cycle; Cell Line; Cyclohex | 1995 |
Phorbol esters and chemotactic factor induce distinct changes in cytoplasmic Ca2+ and pH in granulocytic like HL60 cells.
Topics: Amiloride; Calcium; Cell Differentiation; Cell Line; Dimethyl Sulfoxide; Granulocytes; Humans; Hydro | 1989 |